Research opportunities in clinical research
Funding opportunities
Our funding schemes accept research across the clinical and translational pipeline, as well as supporting clinical academic careers.
We support a broad portfolio of clinical and translational research through response mode funding, initiatives and investments in clinical infrastructure.
We aim to maximise patient benefit through high-impact early phase and first-in-human trials, ambitious and innovative trial designs, and our core-funded supporting infrastructure, which together enable us to learn as much as we can from the patients on our trials.
We're also committed to ensuring that clinical academics have the support they need to develop a career in cancer research, and we have a range of opportunities for clinical researchers at all career levels.
Funding schemes
From September 2024, we will be opening a new clinical research funding scheme which will replace all current clinical funding schemes available
| Scheme |
|---|
| Clinical Research Funding Scheme A modular funding scheme that funds high-quality clinical research, associated translational research, and collection of samples and data. |
Develop your research career
We have a variety of fellowships, bursaries and other career development opportunities for academic and clinician researchers, whether you're new to the lab or looking for funding to start your independent research group.
Strategic priorities
Our overarching aims are to maintain a broad portfolio of clinical research that maximises patient impact, and to learn as much as we can from the patients on our trials.
We have set out our priorities, and how we intend to achieve them, in our clinical research statement of intent, which is used as a basis for strategic discussion by the Clinical Research Committee.
Our research strategy
We invest in creative people who can deliver research of the highest quality. Our strategy shapes how we'll discover more about the mechanisms of how cancer develops and progresses to unlock new and better ways to prevent, detect and treat it.
Our clinical portfolio
Our broad portfolio of clinical trials and associated research spans treatment modalities and disease sites. Explore some recent highlights from our clinical portfolio in the case studies below.
£58.7 million to train the next generation of clinician scientists
We have announced that universities across Scotland and England are set to receive a multimillion-pound cash injection to train more doctors as clinician scientists, so they can pursue cancer research.
Case study: Geoff Higgins
Dr Geoff Higgins, a CRUK Clinician Scientist and an Honorary Consultant Clinical Oncologist specialising in the management of lung cancer, shared his experiences of applying for his fellowship.
Bringing liquid biopsies into the clinic for prostate cancer
Professor Francesca Demichelis has assembled a team to develop the sensitivity of liquid biopsies as a clinical tool for prostate cancer management.
Infrastructure
Our core-funded infrastructure provides specialist expertise and operational support which you may be able to access as part of your clinical research.
Clinical Trials Units (CTUs)
Our eight CTUs help investigators design, conduct, analyse and publish clinical trials of all phases.
Experimental Cancer Medicine Centre (ECMC) Network
The ECMC Network of 17 adult and 12 paediatric Centres supports early-phase clinical trials and translational research.
Our research nurses
Our 15 Senior Research Nurses facilitate patient recruitment and the delivery of high quality clinical trials and studies.
Our research collaborations
Making progress as quickly as possible means working in partnership with others, especially in areas of research that are hard to deliver.
Stratified Medicine Paediatrics 2 Programme
Our pioneering initiative is bringing the benefits of genetic testing to cancer patients and researchers across the UK.
The International Rare Cancers Initiative (IRCI)
We are a founder member of IRCI, which facilitates the development of international clinical trials for patients with rare cancers.
Clinical trials registration and reporting
As the UK's largest funding of academic clinical studies on cancer, we're committed to ensuring our trials are registered and the results reported. This means that researchers can gain the greatest possible insight form data generated, and maximise the benefit for people affected by cancer.
Trial registration and results reporting are included in our grants terms and conditions. Reflecting our dedication to transparency, we monitor registration and reporting compliance and publish the results annually.
Contact us
Please email: clinicalresearch@cancer.org.uk